News - 27 Jan `23Advances in Vitiligo Treatment Highlighted in 2-Minute Video

New

Research and treatments for vitiligo have seen a significant increase in recent years, offering new possibilities. 

The treatment options for vitiligo are rapidly expanding, with the first Food and Drug Administration-approved treatment leading the way. We are also seeing research in oral Janus kinase inhibitors that could offer a new therapeutic approach, as well as a potential biologic therapy that is being explored. The hope is that these therapies will provide vitiligo patients with more options when it comes to managing their condition, allowing them to lead a healthier and more fulfilling life. 

Prof. John E. Harris, MD, professor and chair of the department of dermatology at the University of Massachusetts Chan Medical School, provides a summary of the latest developments in vitiligo treatment in this 2-minute video from the recent Maui Derm meeting. “This is just the tip of the iceberg. So much is happening. We are really excited about the new emerging treatments for vitiligo,” Harris said.

 

 

      FAQOther Questions

      • Who is prone to vitiligo?

        Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...

      • Is there a traditional medicine to treat vitiligo?

        Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...

      • Shall I try low-fat diet for my vitiligo?

        The relationship between dietary fat and autoimmune diseases like vitiligo is a fascinating yet complex puzzle that continues to intrigue researchers. While the debate rages on...